CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-28 | Alenson Carman Principal Accounting Officer | Sale | −152 | $76.45 | $12K | 0 |
| 2018-09-12 | MARAGANORE JOHN Director | Sale | −0 | 36,209 | ||
| 2018-09-12 | MARAGANORE JOHN Director | Sale | −14,162 | $71.74 | $1.0M | 22,047 |
| 2018-09-11 | MARAGANORE JOHN Director | Sale | −11,155 | $72.52 | $809K | 38,609 |
| 2018-09-11 | MARAGANORE JOHN Director | Sale | −2,400 | $73.82 | $177K | 36,209 |
| 2018-09-10 | Schenkein David P Chief Executive Officer | Option exercise | +8,730 | $31.64 | $276K | 83,849 |
| 2018-09-10 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −8,730 | 137,471 | ||
| 2018-09-05 | Schenkein David P Chief Executive Officer | Option exercise | +72,619 | $2.34 | $170K | 72,619 |
| 2018-09-05 | Schenkein David P Chief Executive Officer | Option exercise | +2,500 | $31.64 | $79K | 75,119 |
| 2018-09-05 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −72,619 | 0 | ||
| 2018-09-05 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −2,500 | 146,201 | ||
| 2018-09-05 | Alenson Carman Principal Accounting Officer | Option exercise | +312 | $52.29 | $16K | 464 |
| 2018-09-05 | Alenson Carman Principal Accounting Officer | Sale | −312 | $83.00 | $26K | 152 |
| 2018-09-05 | Alenson Carman Principal Accounting Officer | Option exercise · Stock option (right to buy) | −312 | 12,266 | ||
| 2018-09-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 60,196 |
| 2018-09-05 | Biller Scott Chief Scientific Officer | Sale | −640 | $82.52 | $53K | 59,556 |
| 2018-09-05 | Biller Scott Chief Scientific Officer | Sale | −2,260 | $83.17 | $188K | 57,296 |
| 2018-09-05 | Biller Scott Chief Scientific Officer | Sale | −100 | $84.38 | $8K | 57,196 |
| 2018-09-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −3,000 | 10,154 | ||
| 2018-08-30 | Bowden Christopher Chief Medical Officer | Option exercise | +1,700 | $35.16 | $60K | 2,624 |
Page 57 of 63 · 1,252 trades